Tonix in the News :: Tonix Pharmaceuticals Holding Corp. (TNXP)

Clinical Trials Arena | Feb 8, 2022

Long Covid-19: Tonix reveals Phase II trial design plans

Benzinga | Feb 1, 2022

Could This Be A Potential New Weapon In The Fight Against COVID-19?

HCP Live | Nov 6, 2021

Daily Sublingual Cyclobenzaprine Improves Sleep, Pain Outcomes in Fibromyalgia Patients

Maryland.gov | Oct 20, 2021

Tonix Pharmaceuticals expands into Frederick, Md.

The Frederick News-Post | Oct 18, 2021

New Infectious Disease Research and Development Center Opens in Frederick

WDVM News | Oct 18, 2021

Tonix Pharmaceuticals comes to Frederick

Bloomberg | Aug 23, 2021

FDA Grants Full Approval of Pfizer-BioNTech Vaccine (Podcast)

Boston Business Journal | Aug 9, 2021

Biopharma company Tonix expanding to New Bedford

Boston Globe | Aug 2, 2021

Talking Points: N.J. biotech plans to manufacture vaccines in new Mass. plant

Baltimore Business Journal | Jul 27, 2021

New Jersey pharma company to purchase Frederick R&D facility

Benzinga | Jul 15, 2021

More Than Vaccines: Tonix Programs Address the Spectrum of Covid-19 Problems from Prevention, to Infection to Post-Viral Syndrome

Technology Networks | Jun 1, 2021

Dr. Seth Lederman discusses T Cell Immunity and COVID-19 on Technology Networks

Bloomberg | May 25, 2021

Dr. Seth Lederman Discusses COVID-19 Vaccine durability and further development on Bloomberg Radio

Bloomberg | Mar 23, 2021

Dr. Seth Lederman interviewed on Nobel Laureate Economist on Vaccine Equity

Benzinga | Mar 19, 2021

Positive Phase 3 Efficacy Data Bolsters Tonix Pharmaceuticals' Expectations For Phase 3 Confirmatory Trial In Fibromyalgia

Benzinga | Feb 2, 2021

Tonix Pharmaceuticals CEO Believes That Additional COVID-19 Vaccine Research Is Still Needed

ABC FOX Montana | Jan 6, 2021

Dr. Seth Lederman interviewed on ABC FOX Montana to discuss highlights of Tonix’s planned vaccine manufacturing facility in Hamilton, MT

Contagion Live | Dec 4, 2020

Dr. Seth Lederman interviewed on Contagion Live to discuss its COVID-19 vaccine in development

Bloomberg | Jun 9, 2020

Dr. Seth Lederman interviewed on Bloomberg Radio to discuss COVID-19 Vaccine development

Technology Networks | Apr 7, 2020

Dr. Seth Lederman’s interview with the Science Writer for Technology Networks